SMMT is currently covered by 11 analysts with an average price target of $27.93. This is a potential upside of $17.98 (180.7%) from yesterday's end of day stock price of $9.95.
Summit Therapeutics PLC's activity chart (see below) currently has 96 price targets and 111 ratings on display. The stock rating distribution of SMMT is 51.52% BUY, 27.27% HOLD and 21.21% SELL.
Analysts' price targets on this stock were met 52.72% of the time, taking 529.11 days on average.
Highest price target for SMMT is $42, Lowest price target is $8.3, average price target is $27.93.
Most recent stock forecast was given by JEFFREY WALCH from BERNSTEIN. First documented stock forecast 12-Jun-2015.
Currently out of the existing stock ratings of SMMT, 7 are a SELL (21.21%), 17 are a BUY (51.52%), 9 are a HOLD (27.27%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 18-Nov-2026
$8.3
$-1.65 (-16.58%)
$11.9
4 days ago
(18-Nov-2026)
Buy Since 25-Sep-2025
$42
$32.05 (322.11%)
$43
6 days ago
(16-Nov-2026)
Buy Since 12-Mar-2025
$33
$23.05 (231.66%)
$34
6 days ago
(16-Nov-2026)
Hold Since 01-Oct-2026
$18
$8.05 (80.90%)
$20
6 days ago
(16-Nov-2026)
Hold Since 23-Jul-2026
1 months 30 days ago
(23-Sep-2026)
4/26 (15.38%)
$6.02 (35.45%)
15
What is SMMT (Summit Therapeutics PLC) average time for price targets to be met?
Which analyst most recently updated their price target on SMMT (Summit Therapeutics PLC)?
Which analyst has the most public recommendations on SMMT (Summit Therapeutics PLC)?
Which analyst is the currently most bullish on SMMT (Summit Therapeutics PLC)?
Which analyst is the currently most reserved on SMMT (Summit Therapeutics PLC)?